The neurological examination findings, clinical pathology (including Coccidioides immitis IgG/IgM serology) and magnetic resonance imaging (MRI) findings in 13 dogs with a novel form of intracra- 
case it is recommended that multiple lines of diagnostic evidence be utilized to arrive at a diagnosis, sometimes presumptively. Another drawback of serological testing is that a negative result on IgG/IgM titers does not rule out coccidioidomycosis in dogs. 4 False negative serology results in dogs with coccidioidomycosis may be as high as 5-10%. 3 In dogs with central nervous system involvement, the pathological lesion often consists of a focal granuloma, which commonly occurs in the cerebrum, but can occur in the brainstem, cerebellum, and spinal cord as well. 3 Focal granulomatous meningitis has been described as well. 9 On MRI, intracranial coccidioidomycosis typically appears as a focal, well-circumscribed granuloma of variable T2-weighted intensity, typically appearing T1-iso to mildly hypointense pre-contrast and tends to exhibit strong contrast enhancement on T1-weighted postcontrast sequences. 2 In most cases, there is T2/T2-fluid attenuated inversion recovery (FLAIR) hyperintensity surrounding the focal granuloma, often extensive throughout adjacent white matter, characteristic in appearance of perilesional vasogenic edema. 2 Cerebrospinal fluid is often abnormal if it can be safely obtained, and in many cases in our hospital, extensive vasogenic edema, a mass effect, and midline shifts may significantly increase the risk of obtaining a cerebrospinal fluid sample. Cerebrospinal fluid abnormalities commonly include a mixed cell pleocytosis with a predominance of neutrophils compared to mononuclear cells. Coccidioides organisms can occasionally be microscopically observed in cerebrospinal fluid samples. 3 In the absence of direct observation of organisms, which is commonly the case, a presumptive diagnosis of intracranial coccidioidomycosis is often made with serology, clinical pathological findings, imaging characteristics, and a response to antifungal therapy. 4 Due to the common location of the granulomas deep within brain parenchyma, pathological confirmation with biopsy is either difficult or impossible, and likely unnecessarily invasive in most cases. No standard therapeutic protocol exists for treating coccidioidomycosis in dogs. 5 However, fluconazole therapy is recommended due to good penetration into the central nervous system. 6 Amphotericin B and other azole drugs can also be used to treat coccidioidomycosis. In our facility, treatment is recommended for a minimum of 1 year and at least 4 to 6 months beyond clinical resolution, with several repeat negative serologic titers (or less ideally, marked reduction of prior titer values), and a gold standard of MRI evidence of resolution of previously identified intracranial lesions on repeat imaging.
Common MRI imaging characteristics of central nervous system coccidioidomycosis have recently been described. 2 The purpose of this retrospective case series is to document an unusual variant appearance of intracranial coccidioidomycosis that, to the author's knowledge, has not yet been reported in the veterinary literature.
This variant, while overall less common than the classic presentation of a focal granuloma, is unusual and may not be recognized as infection with Coccidioides in clinicians that are otherwise unfamiliar with the imaging characteristics. This is important, as it is presumed that early recognition of intracranial coccidioidomycosis infection, especially by MRI since serology cannot always be relied upon, limits the otherwise high morbidity and mortality associated with this disease.
MATERIALS AND METHODS
The study was a retrospective, case series design and was approved by the hospital director. The medical records database from the Veterinary Neurological Center in Phoenix, AZ was searched for canine patients that presented between January 2000 and July 2017.
Search terms included coccidioidomycosis, coccidiodomycosis-brain, and coccidioidomycosis/Cocci encephalitis or meningoencephalitis. In our database, there is no separate diagnosis for the described variant presentation of intracranial coccidioidomycosis infection, and the available case records were then examined manually for cases that met the inclusion criteria for this study. Signalment, clinical signs/medical history, neurological examination findings, clinical pathology results, Coccidioides serology, MR imaging description, treatment, clinical outcome, follow-up serology, and follow-up MRI (where available) were recorded for each case. Case review and initial decisions for patient inclusion or exclusion were first made by a neurology resident (E.S.), and then reviewed by a board-certified veterinary neurologist (L.S.).
Inclusion criteria were as follows: each included dog had a positive pretreatment IgG titer for Coccidioides and MRI characteristics of bilaterally symmetric T2 hyperintensity throughout the frontal lobes, caudate nuclei, and rostral internal capsule, ± contrast enhancement.
Patients that survived treatment, or were deceased during treatment were included in order to establish general clinical outcome. Of the patients that survived, each case had follow up titers after treatment that were either negative, lower, were consistently low positives (less than or equal to 1:2), and/or had a complete resolution of initial neurological signs. Cerebrospinal fluid analysis was unavailable in many cases, often due to concern of safely obtaining a sample in patients with extensive edema of the forebrain and because the findings are often nonspecific, and therefore was not a criterion for inclusion in this study. The MRI findings used for initial inclusion had been recorded by the patients' primary care clinicians at the time of presentation. These clinicians had been either a board certified veterinary neurologist (L.S., K.K., or S.P.) or a neurology resident (E.S.). These MRI studies were retrieved and re-reviewed using an image analysis workstation (eFilm, Workstation v. 2.1.2; Merge Healthcare; 900 Walnut Ridge Dr., Hartland WI, 53029). Based on this re-review, the neurology resident (E.S.) and one of the veterinary neurologists (L.S.) developed a consensus for final decisions on study inclusion or exclusion. Imaging criteria used to differentiate and define this variant of Coccidioides encephalitis from the more common form were as follows: bilaterally symmetric T2 hyperintensity throughout the frontal lobes, caudate nuclei, and rostral internal capsule, ± contrast enhancement.
RESULTS
Using the medical record search criteria, 167 cases of Coccidioides encephalitis were identified. A total of 18 dogs (10.8%) fit the initial inclusion criteria for the current study. Of these, two cases did not have adequate pre-imaging Coccidioides titer results and were therefore excluded. For one patient, titer testing was not performed by the referral veterinarian prior to advanced neuroimaging, and for the second referral records were unavailable for review due to the length of time since the case was referred.
The remaining 16 cases (16/167, 9.6%) were initially identified as having consistent imaging criteria for inclusion in the study as well as pre-imaging Coccidoides serology testing, but three of the cases (3/16, 18.7%) were seronegative at the time of presumptive diagnosis and were therefore excluded from the study despite being presumptively diagnosed with Coccidioides encephalitis. Two out of these three cases A total of 13 cases met final inclusion criteria for the study, comprising 13/167 (7.8%) of Coccidioides encephalitis cases in the medical records database. Of the 13 dogs, four were male and nine were female. The median age of onset of diagnosis was 6.2 years (range 3.3-10.5 years), and the median weight was 9.6 kg (range 6.7-26.4 kg).
Ten of 13 (76.9%) cases in this study had a body weight of less than 15 kg. Breeds were as follows: Miniature Schnauzer (six dogs), Standard Schnauzer (two dogs), Border Collie (two dogs), Australian Shepherd (one dog), Bichon Frise (one dog), and Mastiff mix (one dog).
Schnauzer breeds comprised a total of eight of 13 (61.5%) cases.
Presenting clinical signs/complaints
Presenting complaints predominantly involved signs of a forebrain encephalopathy, with 10/13 (76.9%) of dogs having seizures on presentation, nine of 13 (69.2%) exhibiting compulsive pacing/wandering behavior, 11/13 (84.6%) exhibiting compulsive circling behavior in a consistent direction, and 12/13 (92.3%) exhibiting changes in mental alertness and alterations of behavior. Behavioral changes were commonly reported as a decrease in behavioral inhibition or aggressive changes. One patient presented to a board certified veterinary behaviorist for these changes, shortly before beginning to exhibit more obvious signs of encephalopathy. Decreased interest in food/water was a common complaint for the dogs exhibiting significant alterations in mentation. 
Clinical pathology and physical examination findings

Neurological examination findings
All 13 dogs exhibited a neuro-localization referable predominantly to the forebrain, often without obvious lateralizing deficits except for a tendency to circle in a given direction. Interestingly, despite the majority of patients exhibiting clinical signs of a severe encephalopathy, only four of 13 (30.8%) dogs had a menace response deficit, and only two of 13 (15.4%) exhibited a decrease in response to noxious facial sensation. Three of 13 (23.1%) exhibited a hemiparesis, one of 13 (7.7%) a tetraparesis, two of 13 (15.4%) had postural response deficits, three of 13 (23.1%) had trismus, one of 13 (7.7%) had cervical paraspinal pain/cervical muscle spasms, one of 13 (7.7%) exhibited a nystagmus, two of 13 (15.4%) strabismus (ventrolateral), one of 13 (7.7%) a severe torticollis, and two of 13 (15.4%) had a decreased gag reflex.
Patients typically appeared obtunded or stuporous, interacted inappropriately with the environment, and would often dramatically compulsively pace/wander until exhaustion or until encountering an obstacle, and then continually head press into that obstacle. In patients with lateralizing signs, they would exhibit wide circling behavior toward the forebrain side with more severe hyperintensity identified on MRI.
Magnetic resonance imaging characteristics
Magnetic resonance imaging for all 13 dogs was performed under general anesthesia, with a 1.0 or 1.5T scanner (GE Heathcare; Milwaukee, WI). A standard imaging protocol was not followed for each case, but all cases included at least T2-weighted transverse, T1-weightedtransverse pre-and postcontrast sequences, acquired as fast spin echo. Other sequences available in the majority of cases included transverse T2-FLAIR, transverse T2*, and transverse and dorsal diffusion weighted imaging/apparent diffusion coefficient maps. An intravenous injection of 118 mg/kg (1 mL/10 lbs) gadobenate dimeglumine (Multihance made by Bracco Diagnostics Inc.) was used to obtain T1-weighted postcontrast images. There is bilaterally symmetric T2-weighted hyperintensity throughout the frontal lobes, caudate nuclei, internal capsules, and to a lesser extent the thalamus and temporal lobes. The majority of the temporal lobes, as well as the parietal and occipital lobes are entirely spared. The brainstem and cerebellum are likewise spared All primary care clinicians involved in independently interpreting the MRI studies were in complete agreement at the time of presentation. In every case (13/13, 100%), there was bilaterally symmetric T2 hyperintensity within the caudate nuclei (which often appeared abnormally enlarged), the frontal lobes bilaterally, and internal capsules bilaterally, occasionally extending caudally within the cortical white matter to partially involve the parietal and temporal lobes, but invariably sparing the occipital lobes (Figures 1-3, and 5 ). These regions were T2-FLAIR hyperintense in cases where that sequence was available. The regions of hyperintensity appear isointense to mildly hypointense on T1-weighted images, and were predominantly noncontrast enhancing on T1-weighted postcontrast images, although some focal, faint, or wispy contrast enhancement was occasionally observed but was disproportionate to the extent of hyperintensity that was present (Figure 3) . In several cases, the T2/T2-FLAIR hyperintensity could be seen to extend into the diencephalon/rostral mesencephalon. These patients often exhibited a hemiparesis and a torticollis was observed in one patient with T2/T2-FLAIR hyperintensity extending unilaterally into the mesencephalon. Interestingly, two of 13 (15.4%) patients had unilateral concurrent ischemic strokes to the caudate nuclei (Figures 3 and 4) .
Treatment
All patients that survived (11/13, 84.6%) received oral antifungal treatment and a short course of prednisone at an initial anti-inflammatory dosage (0.5-1 mg/kg/day) typically for 7 to 10 days, tapered to discontinuance over 3 to 4 weeks. All animals receiving antifungal therapy initially received fluconazole (5-10 mg/kg PO every 12 h), and one patient was switched from fluconazole to posaconazole over a year after diagnosis due to a repeat IgG titer increasing from 1:2 to 1:32.
That patient was still alive and neurologically normal several years after diagnosis before being lost to follow-up. For the patients that had seizures, anti-epileptic therapy was initiated with either phenobarbital, levetiracetam, or zonisamide at standard dosages. Levetiracetam was most commonly used as an anti-epileptic drug due to concern of hepatotoxicity from concurrent treatment with phenobarbital or zonisamide and fluconazole. Two patients that had chronic grand F I G U R E 3 Brain magnetic resonance images of a 5 year old, male neutered Australian Shepherd. A, T2-weighted transverse image demonstrating similar bilaterally symmetric hyperintensity within the frontal lobes and caudate nuclei. B, Transverse T2-weighted fluid-attenuated inversion recovery image demonstrating corresponding hyperintensity. C, T1-weighted, postcontrast transverse image demonstrating faint bilateral contrast enhancement. Visible within the right caudate nucleus is a wedge-shaped, well-demarcated lesion (arrowheads) identified as an ischemic infarction in Figure 4 . D, A T1-weighted postcontrast parasagittal image demonstrating the faint contrast enhancement predominantly involving and surrounding the caudate nucleus and frontal lobe, and also surrounding the infarction F I G U R E 4 Brain magnetic resonance images of the same patient as in Figure 3 . A, Diffusion-weighted imaging in the dorsal plane at the level of the caudate nuclei, demonstrating marked hyperintensity that corresponds to the wedge-shaped ischemic lesion (arrowhead) visible in Figure 3C and D. B, Apparent Diffusion Coefficient map in the dorsal plane at the level of caudate nuclei, demonstrating restricted diffusion in the same wedge-shaped lesion (arrowhead) mal seizure activity but were otherwise neurologically normal after fluconazole treatment received potassium bromide for chronic antiepileptic maintenance therapy. Denamarin was commonly prescribed as a liver support supplement.
Clinical outcomes
The dogs that survived (11/13, 84.6%) had a normal neurological examination at varying times post-diagnosis (range 3 months-1.5 years).
F I G U R E 5
Brain magnetic resonance images of the same patient as in Figures 3 and 4 . Sequential T2-weighted transverse sequences through the remainder of the brain, demonstrating the same relative sparing of the parietal, temporal, occipital lobes, and brainstem and cerebellum as found in the first patient (Figures 1 and 2 Figure  6A , eight years later. D, T2-weighted midline sagittal image 8 years later, demonstrating marked atrophy of the interthalamic adhesion as in Figure 6C . Vasogenic edema and swelling of the cerebellum with mild herniation of the caudoventral cerebellar vermis at the level of the foramen magnum can also be seen in the last image, secondary to an acute hemorrhagic stroke of the left cerebellar hemisphere which prompted this repeat imaging. This was considered unrelated to prior Coccidioides infection encephalopathy correlated both with a decreased dosage of fluconazole and an increased Coccidioides IgG titer, the brain atrophy appeared subjectively similar to the previous two cases and was not considered to be more severe.
Repeat Imaging
DISCUSSION
The purpose of this retrospective study was to describe the MRI characteristics, clinical pathology findings, and neurological examination findings for a variant of Coccidioides encephalitis that was observed in a group of dogs at the authors' referral veterinary practice. We were unable to find a previous report of this variant in the veterinary literature at the time of this study. Intracranial coccidioidomycosis is comparatively rare, only occurring in specific regions of the world, and has only recently been more thoroughly described in the veterinary literature. 2 The cases described in our study had characteristics that were inconsistent with the more typically described presentation of focal granulomatous lesions in the central nervous system. The dogs in this study all had bilaterally symmetric T2 hyperintensities suggestive of vasogenic and cytotoxic edema within the frontal lobes, caudate nuclei, and internal capsules bilaterally with minimal or no contrast enhancement. An improved awareness of these variant MRI findings could be important for clinical management because 5-10% of patients with Coccidoides infection can be seronegative. 3 Our observed rate of 18.7% seronegativity with active Coccidioides infection was also higher than the previously reported 5-10% in dogs. 3 This higher rate of seronegativity could have been influenced by the small number of patients in this retrospective study and should be interpreted with caution. Three of 16 initially included dogs were excluded from our study because they did not meet all of the required serologic criteria. However, these cases may warrant consideration for prognosis purposes. If we had included them, there would have been a 13/16 (81.2%) long-term favorable survival for potential cases of this variant of Coccidioides encephalitis in dogs in our study population. One case died secondary to cardiac arrest under anesthesia for the MRI, but the MRI did not reveal evidence of brain herniation. Another patient died due to severe concurrent hemorrhagic gastroenteritis, and the third was euthanized at the time of diagnosis due to MR imaging evidence of brain herniation. It is possible that earlier recognition of the Coccidioides encephalitis in these three cases may have provided a more favorable outcome, particularly for the patient that died secondary to concurrent illness and the patient that was euthanized for brain herniation. It is also worth considering that we had initially identified a total of 18/167 (10.8%) of presumed Coccidioides encephalitis cases in our database that all had the same imaging characteristics as the 13 included dogs, but ultimately we had to exclude two cases due to a lack of pre-imaging serology testing.
All patients that survived initially made a complete clinical recovery with antifungal treatment, and had a favorable long-term prognosis. While a brief anti-inflammatory course of prednisone was utilized in most patients, this would not be expected to confound the interpretation of response to treatment in this study. Other possible etiological causes for the encephalitis observed on MRI, such as a meningoencephalitis of unknown (autoimmune) etiology would not be expected to respond favorably long-term to brief corticosteroid therapy at anti-inflammatory doses, as immunosuppressive prednisone (>2 mg/kg/day) and often additional immunosuppressive medications are commonly utilized to treat these cases. Meningoencephalitis from another infectious etiology would also be unlikely to respond long-term to a brief anti-inflammatory course of prednisone without addressing the underlying infectious cause. Additionally, for all patients in this study that survived, a decrease in the Coccidioides IgG titer was documented after initiating antifungal therapy and after a clinical resolution of neurological signs. One patient in this study had a decrease in titer initially from 1:32 to 1:8, 4 months after initiating treatment, a subsequent increase to 1:16, 3 months later after treatment was inappropriately altered by the owner, and had a documented recurrence of encephalopathic signs correlating to this increased titer.
After appropriate treatment was reinstated, this patient had a subsequent improvement in neurological signs and is clinically doing well at the time of this study.
It has been previously reported that patients with intracranial Coccidioides infection have a guarded to poor prognosis due to poor drug penetration into the central nervous system. 3 This was not the case for dogs included in the current study. Prognosis with antifungal treatment may therefore be more favorable than previously reported, with 11/13 (84.6%) of the seropositive patients in the current study surviving long-term and with a full clinical recovery. It should be noted that not all patients were able to discontinue antifungal therapy, and some of the cases required long-term anti-epileptic therapy as well. Of the two patients that did not survive, one had a severe concurrent comorbidity (hemorrhagic gastroenteritis) on presentation, which likely The presence of severe, near complete atrophy of the caudate nuclei bilaterally, frontal lobe atrophy and atrophy of the interthalamic adhesion in the patients that were re-imaged was also surprising.
Given that the observed atrophy only occurred in the regions of the brain exhibiting vasogenic and cytotoxic edema on MRI, one hypothesis is that the same underlying pathophysiological mechanism could explain both the bilaterally symmetrical imaging changes and bilaterally symmetrical atrophy-for example, a vasculitis or metabolic origin as described above. However, an alternative hypothesis would be that the edematous changes caused secondary hypoxic damage The current study was limited by a lack of histopathological confirmation of intracranial Coccidioides infection for included dogs. Unfortunately, the two dogs that did not survive did not undergo necropsy.
These cases had imaging characteristics consistent with the other cases in this study, and therefore were inconsistent with those more commonly reported in cases of Coccidioides encephalitis. It is possible they had a different pathophysiological mechanism and histopathology could have helped elucidate this. The authors propose that the involvement of the frontal lobes and caudate nuclei in all included cases could indicate a possible underlying metabolic, concurrent immunemediated response to the infection, and/or a vasculitis. This possibility is perhaps supported by the observation that two patients in this study (2/13, 15.4%) experienced ischemic infarctions, and both to the caudate nuclei. Deep infarctions have been described in humans with Coccidioides encephalitis. 10, 11 Another limitation was the retrospective nature of the study and a comparatively small case number. Additionally, it would have been ideal to have repeat MRI on all patients in the study to document resolution of pathology previously identified on MRI. In the absence of this, dramatic clinical improvement and a decreasing Coccidioides IgG titer was deemed acceptable for the purposes of this study.
In conclusion, the current study describes characteristics of a variant of Coccidioides encephalitis in a group of dogs. To the author's knowledge, this variant has not been previously reported. The clinical and MRI characteristics were uniform across all cases, and this information could aid in earlier diagnosis and more prompt treatment for future dogs. These characteristics may be particularly useful in cases with Coccidioides seronegativity, as clinicians could use these characteristics to arrive at a presumptive diagnosis of Coccidioides encephalitis and initiate early treatment, which may provide a more favorable clinical outcome. The three cases that underwent repeat imaging all exhibited severe, bilateral atrophy of the caudate nuclei, as well as atrophy of the frontal lobes and interthalamic adhesion, yet they appeared largely neurologically normal and had a favorable longterm outcome. Necropsy and histopathologic confirmation would be an important component of future research, and may also help elucidate an underlying pathophysiological mechanism of this unusual encephalitis, such as a metabolic, immune-mediated response or vasculitis. Schnauzer breeds and dogs weighing less than 15 kg represented the majority of patients in this study, which may suggest a breed predilection for this condition in Schnauzers or small breed dogs. Further research would be needed to confirm these hypotheses. 
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